PureTech Health plc

119.40pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:PRTCHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR (1.36%)
Div yield —
ROE 0.38%
Biotechnology
Beta (5Y) 0.75
PE TTM 203.0
TSR TTM (9.55%)
Mkt cap £292.7M
ROIC (6.91%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
141p
17.99%
(62.10%)
Hold 4|6|2|4|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
2.19
2.34
2.31
2.48
5.41%
8.57%
9.37%
11.64%
Revenue$M
18.69
18.55
19.55
19.97
11.16%
6.59%
8.73%
5.04%
Peers (US$393.9M)
Cap (US$)
PE
352.4M
—
394.0M
—
Capital
TTM
5Y
10Y
Leveragex
0.492
0.083
0.077
EBIT/Intx
1.685
0.118
0.113
Own earn%
80.34
106.86
61.52
Sh yield%
29.74
1.69
3.18
Owners
Insiders/Inst%
5.22
84.70
Short interest%
2.61
SBC / revenue%
4.86
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
15–23
$1 testx
0.0
Incr. ROIC%
1